AssetMark Inc’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48M Buy
95,720
+9,181
+11% +$142K ﹤0.01% 839
2025
Q1
$1.29M Buy
86,539
+372
+0.4% +$5.53K ﹤0.01% 820
2024
Q4
$1.14M Buy
86,167
+5,185
+6% +$68.7K ﹤0.01% 823
2024
Q3
$1.15M Buy
80,982
+4,500
+6% +$64K ﹤0.01% 764
2024
Q2
$990K Buy
76,482
+890
+1% +$11.5K ﹤0.01% 769
2024
Q1
$1.05M Buy
75,592
+3,864
+5% +$53.7K ﹤0.01% 721
2023
Q4
$1.02M Buy
71,728
+193
+0.3% +$2.75K ﹤0.01% 669
2023
Q3
$1.11M Buy
71,535
+1
+0% +$15 ﹤0.01% 598
2023
Q2
$1.12M Buy
71,534
+4,946
+7% +$77.7K ﹤0.01% 590
2023
Q1
$1.1M Buy
66,588
+51,648
+346% +$851K ﹤0.01% 587
2022
Q4
$233K Buy
14,940
+1,090
+8% +$17K ﹤0.01% 798
2022
Q3
$180K Buy
13,850
+988
+8% +$12.8K ﹤0.01% 776
2022
Q2
$181K Sell
12,862
-960
-7% -$13.5K ﹤0.01% 753
2022
Q1
$198K Buy
13,822
+1,152
+9% +$16.5K ﹤0.01% 731
2021
Q4
$173K Buy
12,670
+667
+6% +$9.11K ﹤0.01% 728
2021
Q3
$197K Buy
+12,003
New +$197K ﹤0.01% 570
2021
Q1
Sell
-62,049
Closed -$1.13M 1523
2020
Q4
$1.13M Buy
62,049
+24,680
+66% +$449K 0.01% 343
2020
Q3
$667K Buy
37,369
+9,134
+32% +$163K ﹤0.01% 375
2020
Q2
$506K Buy
28,235
+8,843
+46% +$158K ﹤0.01% 384
2020
Q1
$294K Sell
19,392
-70,986
-79% -$1.08M ﹤0.01% 431
2019
Q4
$1.78M Buy
90,378
+43,104
+91% +$850K 0.01% 317
2019
Q3
$813K Buy
47,274
+39,829
+535% +$685K 0.01% 331
2019
Q2
$132K Buy
7,445
+6,075
+443% +$108K ﹤0.01% 549
2019
Q1
$28K Buy
+1,370
New +$28K ﹤0.01% 815